Abstract 4140084: A Case of Transient Cortical Blindness occurring during Percutaneous Transluminal Coronary Angiography for Acute Coronary Syndrome.

Description of case: A 55 yo man with no PMHx presented with a few hours of intermittent left-sided chest tightness. Serial EKG revealed dynamic ST-T wave changes in lateral leads—Figure 1. His lipid panel was abnormal, and the High-Sensitive Troponin T trended up—table 1. Based on the hemoglobin A1C result of 10.6, he was newly diagnosed with DM. Coronary angiography shows two vessel diseases. The left circumflex artery's first obtuse marginal artery branch (LCX-OM1) received a stent in the first instance. During the planned PTCA for treatment of LAD 48 hours after, he developed sudden bilateral loss of vision while on the table just before stent deployment. In this case, with the emergence of the symptom of vision loss, PTCA was halted to allow the operator to rule out an acute cerebrovascular accident (CVA) through urgent CT head and MRI brain scans. He consented to complete the LAD PTCA the day after, which achieved the intended restenosis without complications. Discussion: Bilateral transient cortical blindness (TCB) is a reversible syndrome of vision loss affecting both eyes in the presence of normal visual pathways due to a brief disturbance in the occipital cortices. TCB is more commonly associated with cerebral angiography but has been rarely reported after coronary angiography. Angiographic contrast toxicity is one of the proposed pathophysiologic mechanisms. During our case, approximately 30 mL of iohexol was used before TCB, while about 120 mL of iodixanol was used for the repeat and conclusive procedure. We are not aware of a previous report in which PTCA was recommenced hours after being halted due to TCB in a patient suffering acute coronary syndrome. The absence of symptom recurrence when the PTCA was recommenced, which underscored the benign nature of TCB, enabled the patient to receive conclusive, definitive treatment for his acute coronary condition.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4140084
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4140084: A Case of Transient Cortical Blindness occurring during Percutaneous Transluminal Coronary Angiography for Acute Coronary Syndrome.

Iyad Farouji, Stanley A. Szwed, Adeniyi Adelakun, Ahmad W. Haddad
Circulation
Cerebrovascular and Carotid Artery Diseases
article

Abstract 4140084: A Case of Transient Cortical Blindness occurring during Percutaneous Transluminal Coronary Angiography for Acute Coronary Syndrome.

Iyad Farouji, Stanley A. Szwed, Adeniyi Adelakun, Ahmad W. Haddad
article en

Abstract

Description of case: A 55 yo man with no PMHx presented with a few hours of intermittent left-sided chest tightness. Serial EKG revealed dynamic ST-T wave changes in lateral leads—Figure 1. His lipid panel was abnormal, and the High-Sensitive Troponin T trended up—table 1. Based on the hemoglobin A1C result of 10.6, he was newly diagnosed with DM. Coronary angiography shows two vessel diseases. The left circumflex artery's first obtuse marginal artery branch (LCX-OM1) received a stent in the first instance. During the planned PTCA for treatment of LAD 48 hours after, he developed sudden bilateral loss of vision while on the table just before stent deployment. In this case, with the emergence of the symptom of vision loss, PTCA was halted to allow the operator to rule out an acute cerebrovascular accident (CVA) through urgent CT head and MRI brain scans. He consented to complete the LAD PTCA the day after, which achieved the intended restenosis without complications. Discussion: Bilateral transient cortical blindness (TCB) is a reversible syndrome of vision loss affecting both eyes in the presence of normal visual pathways due to a brief disturbance in the occipital cortices. TCB is more commonly associated with cerebral angiography but has been rarely reported after coronary angiography. Angiographic contrast toxicity is one of the proposed pathophysiologic mechanisms. During our case, approximately 30 mL of iohexol was used before TCB, while about 120 mL of iodixanol was used for the repeat and conclusive procedure. We are not aware of a previous report in which PTCA was recommenced hours after being halted due to TCB in a patient suffering acute coronary syndrome. The absence of symptom recurrence when the PTCA was recommenced, which underscored the benign nature of TCB, enabled the patient to receive conclusive, definitive treatment for his acute coronary condition.

CirculationVol. 150(Suppl_1)
St. Mary's Hospital (US), Saint Michael's Medical Center (US)
Good health and well-being
Openalex Percentile: Top 61%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 4140084: A Case of Transient Cortical Blindness occurring during Percutaneous Transluminal Coronary Angiography for Acute Coronary Syndrome. — Iyad Farouji, Stanley A. Szwed, et al. · Circulation (2024) | TGRS Research Map | TGRS